Biotechnology Is Eli Lilly Winning The War On Weight Loss Drugs? Zepbound Overtakes Wegovy In US Prescriptions – Novo Nordisk (NYSE:NVO), Eli Lilly and Co (NYSE:LLY) Read more
Biotechnology Oprah Winfrey Tackles Weight Loss Drug Stigma In Prime-Time Special Amid Wegovy-Ozempic Frenzy: ‘For 25 Years, Making Fun Of My Weight Was National Sport’ – Novo Nordisk (NYSE:NVO) Read more
Biotechnology Inconsistent Insurance Coverage For Weight Loss Drugs – Novo Nordisk’s GLP-1s Face Hurdles Despite Health Benefits – Novo Nordisk (NYSE:NVO) Read more
Biotechnology Top 7 Biotech Winners Of Novo Nordisk, Eli Lilly’s Outsourcing Strategy For Weight-Loss Drugs: Goldman Sachs – Agilent Technologies (NYSE:A), Avantor (NYSE:AVTR) Read more
Biotechnology Pharmaceutical Crime Jumps 50% As Criminals Seek To Capitalize Rising Tide of Counterfeit Weight-Loss Drugs – Novo Nordisk (NYSE:NVO) Read more
Biotechnology Anti-Counterfeiting Group Identifies Fake Diabetes Drug Ozempic in 16 Countries: Sparks Patient Harm Concerns – Novo Nordisk (NYSE:NVO) Read more
Opinion Thinking about trading options or stock in Oracle, Cardinal Health, Hewlett Packard Enterprise, Novo Nordisk, or Victoria’s Secret? – Cardinal Health (NYSE:CAH), Hewlett Packard (NYSE:HPE) Read more
Biotechnology Novo Nordisk’s Game-Changer: FDA Approves Weight Loss Sensation Wegovy For Heart Health, Potential Insurance Coverage – Novo Nordisk (NYSE:NVO) Read more
Stockmarkets Novo Nordisk tackles harm from Ozempic fakes with global authorities Reuters via biedexmarkets.com Read more
Biotechnology Novo Nordisk Sets Timeframe For Its Next-Gen Experimental Obesity Drug – Novo Nordisk (NYSE:NVO) Read more